je.st
news
Tag: fda
Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval Of EVOMELA (melphalan) For Injection
2016-03-30 07:12:27| drugdiscoveryonline Home Page
Ligand Pharmaceuticals Incorporated announces thatSpectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, received approval from the U.S. Food and Drug Administration (FDA) of EVOMELA
Tags: partner
approval
spectrum
receives
UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma
2016-03-23 21:16:09| Biotech - Topix.net
The U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a history of severe attacks despite taking medication. The drug, Cinqair, part of a new wave of biotech drugs for severe asthma, is administered intravenously every four weeks in combination with other drugs.
Tags: update
drug
severe
biotech
CBP Updates Four FDA Data Elements
2016-03-21 09:00:00| Expeditors Newsflash - Americas Edition
Expeditors Newsflash - Americas Edition
Tags: data
updates
elements
fda
CBP Announces FDA ACE Webinar
2016-03-18 09:00:00| Expeditors Newsflash - Americas Edition
Expeditors Newsflash - Americas Edition
Tags: ace
announces
fda
webinar
FDA Clears First Smart Bone Conduction Solution Indicated For Significant Mixed Hearing Loss
2016-03-15 06:40:49| Wireless - Topix.net
Cochlear Limited , the global leader in implantable hearing solutions, announced the U.S. Food and Drug Administration cleared the Cochlear Baha 5 SuperPower Sound Processor for use in the United States. Designed for children and adults with higher degrees of mixed hearing loss, the Baha 5 SuperPower is engineered to make difficult listening situations easier and more enjoyable.
Tags: significant
loss
solution
smart
Sites : [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] next »